Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Thrombocytosis 1Recurrence 1Primary Myelofibrosis 1Polycythemia 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Juvenile 1Disease 1

Interventions

venetoclax 188Azacitidine 160Cytarabine 127fludarabine 96Cyclophosphamide 74Specimen Handling 68fludarabine phosphate 56Daunorubicin 53Biopsy 49Decitabine 47Whole-Body Irradiation 42Mycophenolic Acid 40Idarubicin 40Busulfan 37Tacrolimus 35Injections 35Granulocyte Colony-Stimulating Factor 35Melphalan 32Stem Cell Transplantation 30gilteritinib 25Filgrastim 25CPX-351 25decitabine and cedazuridine drug combination 23Peripheral Blood Stem Cell Transplantation 22Etoposide 20Mitoxantrone 19Cladribine 19ivosidenib 18Thiotepa 17Sirolimus 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Acute × imetelstat × 1 year × Clear all
NCT05583552 2026-05-12

IMpress

GCP-Service International West GmbH

Phase 2 Active not recruiting
46 enrolled 21 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07320235 2026-04-22

IMAGINE

Icahn School of Medicine at Mount Sinai

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡